Weekly topotecan as first-line treatment for recurrent or persistent epithelial ovarian cancer (EOC).

被引：0
|
作者：
Safra, T
Menczer, J
Inbar, M
En-Shem, E
Glezerman, M
Grisaro, D
Ron, I
Levy, T
机构：
[1] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[2] Wolfson Med Ctr, Holon, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：482S / 482S
页数：1
相关论文
共 50 条
  • [1] Weekly topotecan in the treatment of recurrent and persistent epithelial ovarian cancer
    Safra, Tamar
    Inbar, Moshe
    Menczer, Joseph
    Grisaro, Dan
    Glezerman, Marek
    Levy, Tally
    ANNALS OF ONCOLOGY, 2004, 15 : 136 - 136
  • [2] Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer
    Levy, T
    Inbar, M
    Menczer, J
    Grisaru, D
    Glezerman, M
    Safra, T
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 686 - 690
  • [3] Effectiveness of weekly topotecan in patients with recurrent epithelial ovarian cancer
    Vandenput, I.
    Amant, F.
    Neven, P.
    Berteloot, P.
    Leunen, K.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (01) : 83 - 87
  • [4] Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer
    Ngoi, Natalie Y. L.
    Syn, Nicholas L. X.
    Goh, Robby M.
    Goh, Boon Cher
    Huang, Ruby Yun-Ju
    Soon, Yu Yang
    James, Elizabeth
    Cook, Adrian
    Clamp, Andrew
    Tan, David S. P.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (02):
  • [5] Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer
    Safra, Tamar
    Menczer, Joseph
    Bernstein, Rinat
    Shpigel, Shulem
    Inbar, Moshe J.
    Grisaru, Dan
    Golan, Abraham
    Levy, Tally
    GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 205 - 210
  • [6] Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer
    Huinink, WTB
    Gore, M
    Carmichael, J
    Gordon, A
    Malfetano, J
    Hudson, I
    Broom, C
    Scarabelli, C
    Davidson, N
    Spanczynski, M
    Bolis, G
    Malmstrom, H
    Coleman, R
    Fields, SC
    Heron, JF
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) : 2183 - 2193
  • [7] First-line Chemotherapy in Epithelial Ovarian Cancer
    Bookman, Michael A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2012, 55 (01): : 96 - 113
  • [8] Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer
    Le, T.
    Hopkins, L.
    Baines, K. A.
    Rambout, L.
    Fung-Kee-Fung, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (03) : 428 - 431
  • [9] Weekly topotecan for recurrent platinum resistant ovarian cancer
    Abushahin, Fadi
    Singh, Diljeet K.
    Lurain, John R.
    Grendys, Edward C.
    Rademaker, Alfred W.
    Schink, Julian C.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (01) : 53 - 57
  • [10] Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer
    Lawrie, Theresa A.
    Rabbie, Roy
    Thoma, Clemens
    Morrison, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10):
12345